Neon Bloom Inc (NBCO) fair value: what the stock is really worth
As of Sep 21, 2026: fair value of Neon Bloom Inc $0.00, price $0.00, upside -13.3%, quality 36 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Neon Bloom Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range $0.0045 – $0.5250 · fair‑value band $0.0039 – $0.0042 · the $0.0045 price screens above the $0.0039 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Neon Bloom in your weekly email
Every Wednesday you see whether Neon Bloom is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Neon Bloom, Inc. is a principal investment firm specializing in acquisitions. The firm primarily invests in innovative agriculture and ancillary technology products and services across the globe. Neon Bloom, Inc was founded in 2015 and is based in New York, New York.
Stock analysis
Neon Bloom Inc (NBCO) currently trades at $0.0045, while our model-based Fair Value estimate is $0.0039, implying the stock looks roughly 15.4% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 7 models at a data quality of 95/100, which puts the evidence level at low.
Scenario range: $0.0039 (bear) to $0.0042 (bull), the price of $0.0045 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Neon Bloom Inc reported revenue of $4.6M in FY2025 versus $68.3K in FY2021, a compound +186.6%/yr. Reported net income was $586K in FY2025.
Key figures
Market cap $1.3M · P/S ratio 22.2 · EPS (TTM) $−0.4600 · Net margin 12.7% · Return on equity −41.2% · Return on assets (EBIT) −80.9% · Operating margin −534% · Free cash flow −$84.3K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades about 48% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −13%, NBCO screens richer than that median.
Fair Value models
Bear $0.0039Fair Value $0.0039Bull $0.0042
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.6/100
Revenue growth is weak, negative or inconsistent.
Revenue growth 1 year
−85.7%
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.8%
’04
’06
’07
’08
’09
’10
’21
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,883.8% (2021) → −10.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: rate outside our plausibility band
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 650 stocks
Beats the industry median on 4/6 measures
Overall it ranks above its industry peers.
Valuation
Quality Score36 · Below median
Fair Value upside−13% · Above median
Profitability
Return on equity (TTM)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets0% · Above median
Net margin (TTM)13% · Above median
Growth and dividend
Revenue growth0% · Above median
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Biotechnology median · lower = cheaper
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM)22.24× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)16· sector 0
FUTURE (revenue growth)0· sector 0
PAST (return on equity)0· sector 0
HEALTH (low debt)0· sector 97
DIVIDEND (yield)0· sector 23
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Neon Bloom Inc (NBCO) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.0039 versus a price of $0.0045, about −13% upside (overvalued).
What is the fair value of NBCO?
Our model-based fair value for Neon Bloom Inc is $0.0039 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.0045.
What is the quality score of NBCO?
Neon Bloom Inc has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Neon Bloom Inc (NBCO)?
Our model-based price target is the fair value of $0.0039 (as of Sep 23, 2026) from 7 valuation models. Cautious scenario $0.0039, optimistic scenario $0.0042. It is a calculation from audited fundamentals, not an analyst target.
What is the Neon Bloom Inc stock forecast for 2026?
Our models put fair value at $0.0039, about −13% upside versus a price of $0.0045 (overvalued). Cautious scenario $0.0039, optimistic scenario $0.0042. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Neon Bloom Inc (NBCO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Neon Bloom Inc it is $0.0039 per share (as of Sep 23, 2026), against a price of $0.0045. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Neon Bloom Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, NBCO trades above its calculated fair value: price $0.0045, fair value $0.0039, a gap of about −13% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NBCO?
No. The price is what the market pays today ($0.0045); the fair value is what the company's own numbers justify ($0.0039). For Neon Bloom Inc the two are $0.0006 per share apart. That gap is exactly why we show both numbers side by side.
How much is Neon Bloom Inc worth?
The market values Neon Bloom Inc at about $1.3M (market capitalisation, as of Sep 23, 2026). Per share that is $0.0045; our models calculate a fair value of $0.0039 per share.
What do the bullish and bearish scenarios say about NBCO?
Our models span a range for Neon Bloom Inc: cautious scenario $0.0039, base $0.0039, optimistic $0.0042 per share (as of Sep 23, 2026, price $0.0045). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Neon Bloom Inc (NBCO)?
Balance-sheet figures for Neon Bloom Inc (as of Sep 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is NBCO from its 52-week high?
Neon Bloom Inc trades at $0.0045, about 48% below its 52-week high of $0.0087 and at the low of $0.0045 (as of Sep 21, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0039 is for.
Which stocks are comparable to Neon Bloom Inc?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc, argenx SE, Samsung Biologics Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Neon Bloom Inc stock attractive at the current price?
The data as of Sep 23, 2026: price $0.0045, calculated fair value $0.0039 (−13%), Quality Score 36/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NBCO calculated?
We run Neon Bloom Inc through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0039, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Neon Bloom Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Neon Bloom Inc (NBCO)?
The closing price on Sep 21, 2026 was $0.0045. Our model-based fair value is $0.0039, about −13% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Neon Bloom Inc right now?
The price sits above even our optimistic bull case ($0.0042). The favourable scenario is already priced in. The models converge in a tight band ($0.0039 to $0.0042), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Neon Bloom Inc
How large is the market capitalisation of Neon Bloom Inc (NBCO)?
The market capitalisation of Neon Bloom Inc is $1.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Neon Bloom Inc (NBCO)?
The price-to-sales ratio of Neon Bloom Inc is 22.2 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Neon Bloom Inc (NBCO)?
Earnings per share at Neon Bloom Inc are $−0.4600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Neon Bloom Inc (NBCO)?
The net margin of Neon Bloom Inc is 12.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Neon Bloom Inc (NBCO)?
The return on equity (ROE) of Neon Bloom Inc is −41.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Neon Bloom Inc (NBCO)?
On an EBIT basis the return on assets of Neon Bloom Inc is −80.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Neon Bloom Inc (NBCO)?
The operating margin of Neon Bloom Inc is −534% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does Neon Bloom Inc (NBCO) generate?
The free cash flow of Neon Bloom Inc is −$84.3K (fiscal year 2023). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Neon Bloom Inc (NBCO) hold?
Neon Bloom Inc holds more cash than debt, $147K net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Neon Bloom Inc in the live analysis
One click puts Neon Bloom Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 23, 2026